It was shown that serum transforming growth factor (TGF)-β levels were significantly reduced in lupus patients, and TGF-β levels showed a reverse association with disease activity and organ damage in SLE patients (215). This evidence concerns the gene TGFB1 and systemic lupus erythematosus.